Announced Thu, 9 Apr · 21:25 IST
Rights Issue of ₹49.90 Cr Approved at ₹15/Share
Fund Raising View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.7%1-day move
₹11.15
prior close
₹11.96
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.8-2.3-3.8-3.8+3.7+6.5+7.6+8.6+7.6+9.1+3.9-0.4+2.7-29.1
Up moveDown movePending
AI summary
Indrayani Biotech's Rights Issue Committee approved a rights issue of up to 3.25 crore partly paid-up equity shares, raising up to ₹49.90 crore at ₹15 per share (including ₹5 premium). Entitlement ratio is 5 rights shares for every 7 held. Record date is April 28, 2026; issue opens May 27 and closes June 25, 2026. Post-issue share count will rise to 7.81 crore from 4.55 crore. Axis Bank is the banker; India Ratings is the monitoring agency.
Likely market impact
Existing shareholders face ~71% potential dilution; must subscribe or renounce by June 25, 2026 to avoid value erosion.